Порівняння методів
Переглядайте обрані методи поруч; рядки з відмінностями підсвічено.
| Аналіз причинного впливу гетерогенного ефекту лікування× | Зіставлення за показником схильності× | |
|---|---|---|
| Галузь≠ | Причинно-наслідковий висновок | Статистика досліджень |
| Родина≠ | Regression model | Process / pipeline |
| Рік появи≠ | 2015-2016 | 1983 |
| Автор методу≠ | Brodersen et al. (causal impact framework, 2015); Athey & Imbens (HTE estimation, 2016) | Paul Rosenbaum and Donald Rubin |
| Тип≠ | Causal inference / heterogeneous effects estimation | Method |
| Основоположне джерело≠ | Brodersen, K. H., Gallusser, F., Koehler, J., Remy, N., & Scott, S. L. (2015). Inferring causal impact using Bayesian structural time-series models. Annals of Applied Statistics, 9(1), 247-274. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Інші назви≠ | HTE-CausalImpact, CATE causal impact, heterogeneous causal impact, subgroup causal impact analysis | PSM, propensity score weighting, covariate balance |
| Пов'язані≠ | 5 | 3 |
| Підсумок≠ | Heterogeneous treatment effect causal impact analysis extends the Bayesian structural time-series causal impact framework to estimate not just the average effect of an intervention but how that effect varies across subgroups or individual units. By combining counterfactual prediction with conditional average treatment effect (CATE) estimation, it reveals which groups benefit most or least from an intervention. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateНабір даних ↗ |
|
|